Tuberous sclerosis complex: A review of neurological aspects

European Journal of Paediatric Neurology

Volumn 6, Issue 1, 2002, Pages 15-23

  Curatolo, Paolo ^a   Verdecchia, Magda ^a   Bombardieri, Roberta ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Austism; Epilepsy; Mental retardation; Tuberous sclerosis complex

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; STEROID; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AUTISM; BRAIN CORTEX; BRAIN DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG MECHANISM; EPILEPSY; EPILEPTIC FOCUS; EYE DISEASE; HAMARTOMA; HEART DISEASE; HUMAN; INTRACTABLE EPILEPSY; KIDNEY DISEASE; NEUROLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; TUBEROUS SCLEROSIS; VISUAL FIELD DEFECT;

EID: 0036230521     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejpn.2001.0538     Document Type: Review

References (47)

1. Prevalence of tuberous sclerosis estimated by capture-recapture analysis
2. European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16
3. Identification of the Tuberous Sclerosis Gene TSC1 on chromosome 9q34
4. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
5. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor
6. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene
7. Tuberous sclerosis-related gene expressions in normal and dysplastic brain
8. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
9. Epilepsy and especially Infantile Spasms are more frequent among patients with TSC2 mutations
10. New development in neurobiology of tuberous sclerosis complex
11. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: An immunohistochemical, ultrastructural, and immunoelectron microscopic study
12. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma
13. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
14. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin
15. Tuberin amino acid substitutions interfere with the interaction between tuberin and hamartin
16. Tuberous Sclerosis Complex Consensus Conference: Revised clinical diagnostic criteria
17. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients
18. Neurologic and psychiatric features
19. MRI in Bourneville disease: Relationships with EEG findings
20. MR evaluation of tuberous sclerosis: Increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation
21. Clinical role of positron emission tomography in children with tuberous sclerosis complex
22. Neurologic and psychiatric aspects of tuberous sclerosis
23. Frontal lobe epilepsy: EEG-MRI fusioning
24. Tuberous sclerosis: Function follows form
25. Cortical tuber count: A biomarker indicating neurologic severity of tuberous sclerosis complex
26. MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment
27. Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis
28. Autistic behaviour and attention deficits in tuberous sclerosis: A population-based study
29. Sleep disorders and epilepsy in children with tuberous sclerosis: A questionnaire based study
30. Sleep disorders in tuberous sclerosis: A polysomnographic study
31. Autism and infantile spasms in children with tuberous sclerosis
32. Association of tuberous sclerosis of temporal lobes with autism and atypical autism
33. Autism in tuberous sclerosis: Evoked potential evidence for a deficit in auditory sensory processing
34. Autism in tuberous sclerosis complex
35. Therapeutic trial of Vigabatrin in refractory infantile spasms
36. Investigator and Peer Review Groups, Mumford JP, Dumas C, Wood S. Vigabatrin as initial therapy for infantile spasms: A european retrospective study
37. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: Literature review
38. Vigabatrin for refractory partial seizures in children with tuberous sclerosis
39. Severe persistent visual field constriction associated with vigabatrin
40. Visual field changes secondary to Vigabatrin treatment
41. Vigabatrin and GABA concentration inter-relationship in rat extracellular fluid (EDF) from frontal cortex and hippocampus
42. Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: Is young age a favorable factor?
43. Topiramate as therapy for tuberous sclerosis complex-associated seizures
44. Surgical treatment for epilepsy in cerebral tuberous sclerosis
45. Selective epilepsy surgery in tuberous sclerosis
46. Partial epilepsy and tuberous sclerosis: Indications for surgery in disseminated disease
47. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography